| Diagnostic modality | % |
|---|---|
| EUS-guided FNA | 52 |
|
| |
| Pancreatic mass | 47 |
|
| |
| Metastatic site (eg, liver, lymph node) | 5 |
|
| |
| Percutaneous biopsy | 34 |
|
| |
| Pancreatic mass | 14 |
|
| |
| Metastatic site (eg, liver) | 20 |
|
| |
| Surgical biopsy | 7 |
|
| |
| Brushing/biopsy during ERCP | 4 |
|
| |
| Radiographic and/or EUS imaging and clinical course consistent with pancreatic cancer | 3 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.